DUBLIN--(BUSINESS WIRE)--Aug 23, 2018--The "Drug Discovery Technologies" report has been added to ResearchAndMarkets.com's offering.

The report also covers market by end user for drug discovery tools: biopharmaceutical companies, research, academia and Others, including contract research organizations.

In recent years, the drug discovery market has seen remarkable discoveries and rapid progress. This report focuses on the global market of drug discovery tools and provides an updated review to include basic design and its applications in various disease areas. The drug discovery tools include high-throughput screening, bioanalytical tools, proteomics, genomics, bioinformatics and few others, like metabolomics, combinatorial chemistry, nanotechnology and system biology.

These tools are further classified into subcategories for the purpose of this report. The five main application areas described in this report concern different cancer types, cardiovascular diseases, immunological diseases, neurological diseases and others which includes metabolic, endocrinology and genetic diseases.

This report is global in scope and includes analysis of the various regulatory environments, new products and advancements, market projections and market share. Also included in the report are relevant patent analysis and comprehensive profiles of companies that lead the drug discovery tools market. The geographical regions covered are the U.S., Europe and the emerging markets of India, China, Japan, South Korea, Taiwan, Africa, Australia, New Zealand, Canada, among others.

Key players in the drug discovery market include Thermo Fisher Scientific, Agilent Technologies Inc., Shimadzu Corp., Bruker Corp., Illumina Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., and Merck KGaA (including EMD Millipore and Sigma Aldrich).

Key Topics Covered:

1. Introduction

2. Summary and Highlights

3. Market and Technology Background

4. Market Breakdown by Technology Type

5. Market Breakdown by End User

6. Market Breakdown by Disease

7. Market Breakdown by Region

8. Industry Structure

9. Patent Review/New Developments/Regulatory Aspects

10. Analysis of Market Opportunities

11. Company Profiles

Agilent Technologies Inc Ametek Inc. Bayer Technology Services Gmbh Bio-Rad Laboratories Ltd Biocrates Life Sciences AG Biomax Informatics AG Biotek Instruments Inc. Bruker Corp. Carl Zeiss Microimaging Gmbh Compugen Ltd. Danaher Corp. Dassault Systemes GE Healthcare Lifesciences Hamilton Robotics Inc. Hitachi High-Technologies Corp. Human Metabolome Technologies Inc. Illumina Inc. Integrated Dna Technologies Inc. Iroa Technologies Jeol USA Inc. Leco Corp. Lonza Group AG Perkinelmer Inc. Promega Corp. Qiagen N.V. Roche Holding Ltd. Shimadzu Corp. Sidmap LLC Sigma-Aldrich Corp. Somalogic Inc. Thermo Fisher Scientific Inc. Waters Corp.

For more information about this report visit https://www.researchandmarkets.com/research/hn2ms2/drug_discovery?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180823005625/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Discovery



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/23/2018 01:14 PM/DISC: 08/23/2018 01:14 PM